Formoterol on airway smooth muscle and human lung mast cells: a comparison with salbutamol and salmeterol
- 14 January 1994
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 251 (2-3) , 127-135
- https://doi.org/10.1016/0014-2999(94)90392-1
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Formoterol: Pharmacology, molecular basis of agonism, and mechanism of long duration of a highly potent and selective β2-adrenoceptor agonist bronchodilatorLife Sciences, 1993
- The pharmacology of salmeterolLife Sciences, 1993
- Effects of β‐adrenoceptor agonists in human bronchial smooth muscleBritish Journal of Pharmacology, 1993
- A novel method for the evaluation of bronchoactive agents in the conscious guinea pigJournal of Pharmacological Methods, 1991
- The 1990 Lilly Prize Lecture. A way of looking at agonism and antagonism: lessons from salbutamol, salmeterol and other beta‐ adrenoceptor agonists.British Journal of Clinical Pharmacology, 1991
- On the predictive value of experiments in vitro in the evaluation of the effect duration of bronchodilator drugs for local administrationPulmonary Pharmacology, 1989
- Formoterol fumarate, a new β2‐adrenoceptor agonistAllergy, 1989
- Novel and versatile superfusion systemJournal of Pharmacological Methods, 1989
- Salmeterol, a new long acting inhaled beta 2 adrenoceptor agonist: comparison with salbutamol in adult asthmatic patients.Thorax, 1988
- CHARACTERIZATION OF THE RECEPTOR MEDIATING THE ANTI‐ANAPHYLACTIC EFFECTS OF β‐ADRENOCEPTOR AGONISTS IN HUMAN LUNG TISSUE in vitroBritish Journal of Pharmacology, 1980